Krystal Biotech (NASDAQ:KRYS) Stock Price Up 7.1% After Analyst Upgrade
Shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Get Free Report) rose 7.1% during trading on Thursday after Citigroup raised their price target on the stock from $206.00 to $215.00. Citigroup currently has a neutral rating on the stock. Krystal Biotech traded as high as $186.69 and last traded at $188.63. Approximately 82,372 shares traded hands […]
More Stories
Coast Guard Offloads $28 Million Worth of Seized Cocaine in Miami Beach
By Naveen Athrappully The crew of U.S. Coast Guard Cutter Tampa offloaded roughly 3,825 pounds of cocaine valued at over...
NY Loses Nearly $74 Million for Not Revoking Commercial Driver’s Licenses Unlawfully Issued to Foreigners
By Jill McLaughlin The U.S. Department of Transportation will withhold $73.5 million in federal funding from New York for failing...
2nd Round of Iran Peace Talks Could Come This Weekend, Trump Says
By Ryan Morgan A second round of peace talks between the United States and Iran could take place this weekend,...
Historically Low Jobless Claims Signal Stable US Labor Market
By Andrew Moran The number of Americans filing for unemployment benefits remained around historically low levels, signaling a stable U.S....
Alzheimer’s Drugs Have No ‘Meaningful Effect’ on Cognitive Decline: Review
By Zachary Stieber A class of Alzheimer’s drugs that have only been available for several years did not appear to...
Hegseth Says US ‘Locked and Loaded’ to Strike Iran’s Power Plants If No Deal Reached
By Jack Phillips U.S. Secretary of War Pete Hegseth on April 16 urged Iran’s leadership to reach a deal with...